Ellen Goldberg
Director/Board Member at CASTLE BIOSCIENCES, INC.
Net worth: 185 443 $ as of 2024-04-29
Profile
Ellen Goldberg is an Independent Director at Castle Biosciences, Inc. She previously worked as the Vice President-Marketing at Crescendo Bioscience LLC from 2009 to 2011.
Ms. Goldberg holds a graduate degree and an MBA from Stanford University.
She also has an undergraduate degree from Yale University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CASTLE BIOSCIENCES, INC.
0.03% | 2024-03-30 | 9,505 ( 0.03% ) | 185 443 $ | 2024-04-29 |
Ellen Goldberg active positions
| Companies | Position | Start |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Director/Board Member | 2021-07-15 |
Former positions of Ellen Goldberg
| Companies | Position | End |
|---|---|---|
Crescendo Bioscience LLC
 Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Sales & Marketing | 2010-12-31 |
Training of Ellen Goldberg
| Stanford University | Graduate Degree |
| Yale University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CASTLE BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Crescendo Bioscience LLC
Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Commercial Services |
- Stock Market
- Insiders
- Ellen Goldberg
